Articles
Pharma gets social: pharma lessons in social media and clinical trials

Pharma gets social: pharma lessons in social media and clini...

Daniel Ghinn explores what we have learnt to date in how social media can support clinical trials activity. The use of social media in supporting medical research is rapidly moving from experimental pilots to informed strategies. Indeed, an increasing number of...

Articles
Executive perspectives: Stephen Whitehead

Executive perspectives: Stephen Whitehead

Continuing our series of Executive Perspectives, Paul Tunnah speaks to the Chief Exec of the UK’s major pharma industry association, the ABPI, for his views on where we are heading. Following the launch of a new series earlier this year looking at perspectives from those leading organisations and companies, pharmaphorum managed to catch up with…

Articles
QR codes: function not fashion

QR codes: function not fashion

Mark Evans offers top tips on engaging users with QR codes. QR (Quick Response) codes are the current must-have fashion item for your ad campaign. They certainly provide some interesting...

Sales & Marketing

Digital

Market Access

Editor's Picks

  1. ESMO26: Tango sees 82% ORR with combo in pancreatic cancer
  2. Roche offers $15bn for strategic-level deal with Hansoh
  3. ESMO26: Moderna, MSD reveal cancer jab data early after leak
  4. Clinical trial setup times fall sharply in UK
  5. Despite US policy changes, drug prices stay stubbornly high

Newsletters and Deep Dive
digital magazine

Oncology

more

Patients

more

R&D

more